ABPI names new Medical, Innovation and Research director
pharmafile | July 24, 2012 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | ABPI, Bina Rawal, Stephen Whitehead
The ABPI has named its new Medical, Innovation and Research director as Dr Bina Rawal, who will join the trade body’s team in October.
Rawal joins the ABPI from the Wellcome Trust where in her role as head of Clinical Development within the Technology Transfer Division (TTD) she has been responsible for oversight and governance of the clinical pipeline.
Prior to joining the Wellcome Trust, Rawal has held senior roles at Roche and GlaxoWellcome R&D.
Stephen Whitehead, ABPI chief executive, said: “Bina joins our senior team at a critical time for industry when we need to demonstrate the very high value of the UK’s research and development capability in the pharmaceutical industry on the global stage. We need a strong voice for innovation in the industry and Bina’s experience and background will complement that of our members’ to champion science, discovery, research and development and enable it to thrive in the UK.”
Recently appointed chair of the ABPI’s Innovation Board Neil Weir (UCB) said: “We’re delighted that Bina will lead the Medical and Innovation Team at the ABPI and work with members to drive the agenda for innovation in the UK.”
Rawal added: “I am very pleased to be joining the ABPI team and members to lead the campaigns on innovation. I am very excited about working with members, the Innovation Board and many stakeholders to demonstrate and enhance this contribution for the benefit of patients and the UK economy”.
Related Content
The November 2020 issue of Pharmafocus is available to read free online now!
The latest monthly edition of Pharmafocus is available to read for free online now!
UK life sciences industry does not want no-deal Brexit, says ABPI Chief
Prime Minister Boris Johnson’s sudden change of position that the UK is now expecting a …
ABPI Chief Executive Mike Thompson to retire by the end of 2019
The Association of the British Pharmaceutical Industry (ABPI) has announced that its Chief Executive Mike …
